Management and health-related quality of life among patients with prostate cancer in a Kenyan tertiary health facility.

IF 1 4区 医学 Q4 ONCOLOGY Journal of Oncology Pharmacy Practice Pub Date : 2025-01-01 Epub Date: 2023-12-17 DOI:10.1177/10781552231221110
Wairimu Karaihira, Peter N Karimi, Irene W Weru
{"title":"Management and health-related quality of life among patients with prostate cancer in a Kenyan tertiary health facility.","authors":"Wairimu Karaihira, Peter N Karimi, Irene W Weru","doi":"10.1177/10781552231221110","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Advances made in the screening, diagnosis and management of prostate cancer have improved the survival rates of the patients. However, many of these treatments including surgery, radiotherapy, and pharmacotherapy, have an impact on the subsequent health-related quality of life (HRQoL) of these patients. Since it is an important prognostic factor of survival, failure to evaluate the HRQoL and its predictors in these patients typically results in long-term deficits in their overall well-being, that is, their physical, social, emotional, and mental health. The objective of this study was to evaluate the management and HRQoL among patients with prostate cancer at Kenyatta National Hospital.</p><p><strong>Methods: </strong>This was a descriptive cross-sectional study. The sample size of 62 patients who met the eligibility criteria was selected through simple random sampling on the respective clinic days of the cancer treatment centre and urology clinic. Data was collected through a pre-tested structured questionnaire and HRQoL tools which are EORTC-QLQ-C30 and EORTC-QLQ-PR25 and analysed using STATA version 13 software. Descriptive analysis was used to summarise the continuous and categorical variables. Spearman's rho (r<sub>s</sub>) correlation was used to determine the predictors of HRQoL based on the strength and significance of association at 0.05 level of significance.</p><p><strong>Results: </strong>The mean age of the participants was 70.5 (±7.35) years. The majority (52, 83.9%) of the patients had a prostate specific antigen (PSA) above 20 ng/ml. Twenty-one (33.9%) were graded as Gleason group 5 and 41 (66.1%) had stage IV disease at diagnosis. Fifty (80.9%) participants were on hormonal therapy, with most of them being on combined androgen blockade. The overall HRQoL was 65.1. Fatigue, one of the major complaints among these patients, was negatively associated with physical functioning (p = 0.0005), role functioning (p = 0.0026), social functioning (p = 0.0001), financial difficulties (p = 0.0077) and quality of life (p = 0.0050).</p><p><strong>Conclusion: </strong>Fatigue was the most common predictor of poor HRQoL in several scales of measurement. For those on management, frequent assessment of HRQoL should be carried out and interventions instituted immediately.</p>","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":" ","pages":"22-30"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552231221110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Advances made in the screening, diagnosis and management of prostate cancer have improved the survival rates of the patients. However, many of these treatments including surgery, radiotherapy, and pharmacotherapy, have an impact on the subsequent health-related quality of life (HRQoL) of these patients. Since it is an important prognostic factor of survival, failure to evaluate the HRQoL and its predictors in these patients typically results in long-term deficits in their overall well-being, that is, their physical, social, emotional, and mental health. The objective of this study was to evaluate the management and HRQoL among patients with prostate cancer at Kenyatta National Hospital.

Methods: This was a descriptive cross-sectional study. The sample size of 62 patients who met the eligibility criteria was selected through simple random sampling on the respective clinic days of the cancer treatment centre and urology clinic. Data was collected through a pre-tested structured questionnaire and HRQoL tools which are EORTC-QLQ-C30 and EORTC-QLQ-PR25 and analysed using STATA version 13 software. Descriptive analysis was used to summarise the continuous and categorical variables. Spearman's rho (rs) correlation was used to determine the predictors of HRQoL based on the strength and significance of association at 0.05 level of significance.

Results: The mean age of the participants was 70.5 (±7.35) years. The majority (52, 83.9%) of the patients had a prostate specific antigen (PSA) above 20 ng/ml. Twenty-one (33.9%) were graded as Gleason group 5 and 41 (66.1%) had stage IV disease at diagnosis. Fifty (80.9%) participants were on hormonal therapy, with most of them being on combined androgen blockade. The overall HRQoL was 65.1. Fatigue, one of the major complaints among these patients, was negatively associated with physical functioning (p = 0.0005), role functioning (p = 0.0026), social functioning (p = 0.0001), financial difficulties (p = 0.0077) and quality of life (p = 0.0050).

Conclusion: Fatigue was the most common predictor of poor HRQoL in several scales of measurement. For those on management, frequent assessment of HRQoL should be carried out and interventions instituted immediately.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肯尼亚一家三级医疗机构中前列腺癌患者的管理和健康相关生活质量。
导言:前列腺癌筛查、诊断和治疗方面的进步提高了患者的生存率。然而,包括手术、放射治疗和药物治疗在内的许多治疗方法都会对患者随后的健康相关生活质量(HRQoL)产生影响。由于健康相关生活质量是生存的一个重要预后因素,如果不对这些患者的健康相关生活质量及其预测因素进行评估,通常会导致他们的整体健康(即身体、社交、情感和心理健康)出现长期缺陷。本研究旨在评估肯雅塔国立医院前列腺癌患者的管理和 HRQoL:这是一项描述性横断面研究。通过简单随机抽样,在癌症治疗中心和泌尿科诊所各自的门诊日抽取了62名符合资格标准的患者作为样本。数据通过预先测试的结构化问卷和 HRQoL 工具(EORTC-QQLQ-C30 和 EORTC-QQLQ-PR25)收集,并使用 STATA 第 13 版软件进行分析。描述性分析用于总结连续变量和分类变量。在 0.05 的显著性水平下,根据相关性的强度和显著性,使用 Spearman's rho (rs) 相关性来确定 HRQoL 的预测因素:参与者的平均年龄为 70.5 (±7.35) 岁。大多数患者(52 人,83.9%)的前列腺特异性抗原(PSA)高于 20 纳克/毫升。21名患者(33.9%)在确诊时被分级为格里森5级,41名患者(66.1%)处于疾病的IV期。50名参与者(80.9%)正在接受激素治疗,其中大多数人正在接受雄激素联合阻断治疗。总体 HRQoL 为 65.1。疲劳是这些患者的主要主诉之一,与身体功能(p = 0.0005)、角色功能(p = 0.0026)、社会功能(p = 0.0001)、经济困难(p = 0.0077)和生活质量(p = 0.0050)呈负相关:结论:在多个测量量表中,疲劳是最常见的不良 HRQoL 预测因素。对于接受治疗的患者,应经常进行 HRQoL 评估,并立即采取干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
7.70%
发文量
276
期刊介绍: Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...
期刊最新文献
End-of-life symptoms and polypharmacy in lung and other cancer patients receiving palliative care in Turkey. Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL). Pharmacotherapy and psychological support: Integrating pharmacists into comprehensive cancer care - a literature review. Antifungal-drug interactions in oncology: A cross-sectional study highlighting the role of pharmacists. Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: Single-center retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1